Callum Scott

Callum Scott has 15 years’ R&D experience, including over 6 years in industry as a Development Manager. As a Technical Transfer & Formulation Development Manager with Allergy Therapeutics (UK) Ltd., Callum was responsible for all Product Development/CMC activities relating to a novel immunotherapeutic virus-like particle (VLP) vaccine for the treatment of peanut allergic patients (VLP Peanut). This led to a successful investigational new drug (IND) application and the initiation of a Phase I clinical trial. Previously a Development Manager with Benchmark Animal Health Ltd., he managed the development several vaccine projects relevant to animal health. Callum joined knoell Animal Health as a Senior Advisor in Veterinary Product Development in June 2023. He holds a PhD in Molecular Microbiology from Heriot-Watt University and is a chartered member of the Royal Society of Biology.

  • Next: 13-14 Nov 2023 Live online

A Practical Approach to Veterinary Vaccine Development and Registration in the EU

Live online

This event has been designed to give practical advice and guidance on how to successfully develop market approval in the EU. The programme will take participants through a step-by-step approach to the process and will also provide key guidance on how to maintain MA once achieved.

  • 12 CPD hours Focused
  • Presented by Dr Callum Scott